Increased levels of immunological markers in the respiratory tract but not in serum correlate with active pulmonary mycobacterial infection in mice

Clinical Microbiology and Infection

Volumn 15, Issue 8, 2009, Pages 777-786

  Arko Mensah, John ^a   Rahman, M J ^a   Julian E ^b   Horner, G ^a   Singh, M ^c   Fernandez C ^a  

^a STOCKHOLM UNIVERSITY   (Sweden)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c LIONEX DIAGNOSTICS AND THERAPEUTICS GMBH   (Germany)

Author keywords

Antibodies; Cytokine receptors; Cytokines; Lung infection; Mycobacterial infection

Indexed keywords

BCG VACCINE; DEXAMETHASONE; GAMMA INTERFERON; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTERLEUKIN 12; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; BACTERIAL GROWTH; CELL ACTIVATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DIAGNOSTIC VALUE; DISEASE ACTIVITY; FEMALE; IMMUNOASSAY; LUNG; LUNG LAVAGE; LUNG TUBERCULOSIS; MOUSE; MYCOBACTERIUM BOVIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN LOCALIZATION; SERODIAGNOSIS; TISSUE DISTRIBUTION;

BACTERIA (MICROORGANISMS); CORYNEBACTERINEAE; MUS; MYCOBACTERIUM; MYCOBACTERIUM BOVIS;

EID: 69249105016     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2009.02734.x     Document Type: Article

References (29)

1. North RJ, Jung YJ. Immunity to tuberculosis. Annu Rev Immunol 2004; 22: 599-623.
2. Algood HM, Lin PL, Flynn JL. Tumor necrosis factor and chemokine interactions in the formation and maintenance of granulomas in tuberculosis. Clin Infect Dis 2005; 41: 189-193.
3. Ulrichs T, Kaufmann SH. New insights into the function of granulomas in human tuberculosis. J Pathol 2006; 208: 261-269.
4. Flynn JL. Immunology of tuberculosis and implications in vaccine development. Tuberculosis 2004; 84: 93-101.
5. Flynn JL, Chan J. Immunology of tuberculosis. Annu Rev Immunol 2001; 19: 93-129.
6. Rodriguez A, Tjarnlund A, Ivanji J et al. Role of IgA in the defense against respiratory infections: IgA deficient mice exhibited increased susceptibility to intranasal infection with Mycobacterium bovis BCG. Vaccine 2005; 23: 2565-2572.
7. Steingart KR, Ng V, Henry M et al. Sputum processing methods to improve the sensitivity of smear microscopy for tuberculosis: A systematic review. Lancet Infect Dis 2006; 6: 664-674.
8. Walker D. Economic analysis of tuberculosis diagnostic tests in disease control: How can it be modelled and what additional information is needed?. Int J Tuberc Lung Dis 2001; 12: 1099-1108.
9. Farhat M, Greenaway C, Pai M, Menzies D. False-positive tuberculin skin tests: What is the absolute effect of BCG and non-tuberculous mycobacteria? Int J Tuberc Lung Dis 2006; 10: 1192-1204.
10. Pai M, Zwerling A, Menzies D. T-cell-based assays for the diagnosis of latent tuberculosis infection: An update. Ann Intern Med 2008; 149: 177-184.
11. Ling DI, Flores LL, Riley LW, Pai M. Commercial nucleic-acid amplification tests for diagnosis of pulmonary tuberculosis in respiratory specimens: Meta-analysis and meta-regression. PLoS ONE 2008; 3: E1536.
12. Abebe F, Holm-Hansen C, Wiker HG, Bjune G. Progress in serodiagnosis of Mycobacterium tuberculosis infection. Scand J Immunol 2007; 66: 176-191.
13. Lawn SD, Rudolph D, Wiktor S, Coulibaly D, Ackah A, Lal RB. Tuberculosis (TB) and HIV infection are independently associated with elevated serum concentrations of tumour necrosis factor receptor type.1 and beta2-microglobulin, respectively. Clin Exp Immunol 2000; 122: 79-84.
14. Verbon A, Juffermans N, Van Deventer SJ, Speelman P, Van Deutekom H, Van Der Poll T. Serum concentrations of cytokines in patients with active tuberculosis. Clin Exp Immunol 1999; 115: 110-113.
15. Power CA, Wei G, Bretscher PA. Mycobacterial dose defines the Th1/Th2 nature of the immune response independently of whether immunization is administered by the intravenous, subcutaneous, or intradermal route. Infect Immun 1998; 6: 5743-5750.
16. Greenaway C, Lienhardt C, Adegbola R, Brusasca P, McAdam K, Menzies D. Humoral response to Mycobacterium tuberculosis antigens in patients with tuberculosis in the Gambia. Int J Tuberc Lung Dis 2005; 9: 1112-1119.
17. Kanaujia GV, Lam PK, Perry S, Brusasca PN, Catanzaro A, Gennaro ML. Integration of microscopy and serodiagnostic tests to screen for active tuberculosis. Int J Tuberc Lung Dis 2005; 10: 1120-1126.
18. Imaz MS, Comini MA, Zerbini E et al. Evaluation of the diagnostic value of measuring IgG, IgM and IgA antibodies to the recombinant 16-kilodalton antigen of Mycobacterium tuberculosis in childhood tuberculosis. Int J Tuberc Lung Dis 2001; 5: 1036-1043.
19. Wang J, Palmer K, Lötvall J et al. Circulating, but not local lung, IL-5 is required for the development of antigen-induced airway eosinophilia. J Clin Invest 1998; 102: 1132-1141.
20. Lowrie DB, Tascon RE, Bonato VL. Therapy of tuberculosis in mice by DNA vaccination. Nature 1999; 400: 269-271.
21. Guler R, Olleros ML, Vesin D, Parapanov R, Garcia I. Differential effects of total and partial neutralization of tumor necrosis factor on cell-mediated immunity to Mycobacterium bovis BCG infection. Infect Immun 2005; 73: 3668-3676.
22. Condos R, Rom WN, Liu YM, Schluger NW. Local immune responses correlated with presentation and outcome in tuberculosis. Am J Respir Crit Care Med 1998; 157: 729-735.
23. Taha RA, Kotsimbos TC, Song YL, Menzies D, Hamid Q. IFN-gamma and IL-12 are increased in active compared to inactive tuberculosis. Am J Respir Crit Care Med 1997; 55: 1135-1139.
24. Kupeli E, Karnak D, Beder S, Kayacan O, Tutkak H. Diagnostic accuracy of cytokine levels (TNF-alpha, IL-2 and IFN-gamma) in bronchoalveolar lavage fluid of smear-negative pulmonary tuberculosis patients. Respiration 2008;75: 73-78.
25. Giri PK, Verma I, Khuller GK. Enhanced immunoprotective potential of Mycobacterium tuberculosis Ag85 complex protein based vaccine against airway Mycobacterium tuberculosis challenge following intranasal administration. FEMS Immunol Med Microbiol 2006; 47: 233-241.
26. Wayne LG. Dormancy of Mycobacterium tuberculosis and latency of disease. Eur J Clin Microbiol Infect Dis 1994; 13: 908-914.
27. Jackett PS, Bothamley GH, Batra HV, Mistry A, Young DB, Ivanyi J. Specificity of antibodies to immunodominant mycobacterial antigens in pulmonary tuberculosis. J Clin Microbiol 1988; 26: 2313-2328.
28. Rodríguez A, Troye-Blomberg M, Lindroth K, Ivanyi J, Singh M, Fernández C. B- and T-cell responses to the mycobacterium surface antigen PstS-1 in the respiratory tract and adjacent tissues. Role of adjuvants and routes of immunization. Vaccine 2003; 21: 458-467.
29. Araujo Z, Waard JH, Fernández C et al. Study of the antibody response against Mycobacterium tuberculosis antigens in Warao Amerindian children in Venezuela. Mem Inst Oswaldo Cruz 2004; 99: 517-524.